Switch to:

Eidos Therapeutics Other Current Assets

: $5.98 Mil (As of Sep. 2020)
View and export this data going back to 2018. Start your Free Trial

Eidos Therapeutics's other current assets for the quarter that ended in Sep. 2020 was $5.98 Mil.

Eidos Therapeutics's quarterly other current assets declined from Mar. 2020 ($3.95 Mil) to Jun. 2020 ($3.82 Mil) but then increased from Jun. 2020 ($3.82 Mil) to Sep. 2020 ($5.98Mil).

Eidos Therapeutics's annual other current assets increased from Dec. 2017 ($0.48 Mil) to Dec. 2018 ($1.79 Mil) increased from Dec. 2018 ($1.79 Mil) to Dec. 2019 ($4.68 Mil).

Eidos Therapeutics Other Current Assets Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Eidos Therapeutics Annual Data
Dec16 Dec17 Dec18 Dec19
Other Current Assets 0.01 0.48 1.79 4.68

Eidos Therapeutics Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Other Current Assets Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.40 4.68 3.95 3.82 5.98

Eidos Therapeutics Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:

Trade Receivables

The assets grouped under other current assets are most commonly:

Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.

Eidos Therapeutics Other Current Assets Related Terms

Eidos Therapeutics Other Current Assets Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)